Daniel R Weltzien
CIK 1762224 · View on SEC EDGAR ↗
First SEC filing: Jan. 3, 2019 · Latest: Jan. 3, 2019
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | BMI | A | 738 | — | — | 6,190 Direct | +13.54% | Acquired | (price as of 2026-08-21) |
| March 6, 2026 | BMI | F | 41 | $148.85 | $6,103 | 5,452 Direct | -0.75% | Disposed | -13.6% (price as of 2026-08-21) |
| March 3, 2026 | BMI | F | 449 | $148.76 | $66,793 | 5,493 Direct | -7.56% | Disposed | -13.6% (price as of 2026-08-21) |
| Feb. 27, 2026 | BMI | F | 47 | $152.43 | $7,164 | 5,942 Direct | -0.78% | Disposed | -15.7% (price as of 2026-08-21) |
| Feb. 12, 2026 | BMI | A | 1 | $174.41 | $174 | 112 Indirect | +0.90% | Acquired | -26.3% (price as of 2026-08-21) |
| Feb. 12, 2026 | BMI | A | 1,193 | — | — | 5,989 Direct | +24.87% | Acquired | (price as of 2026-08-21) |
| March 7, 2025 | BMI | A | 382 | — | — | 4,796 Direct | +8.65% | Acquired | (price as of 2026-08-21) |
| March 5, 2025 | BMI | F | 373 | $209.74 | $78,233 | 4,414 Direct | -7.79% | Disposed | -38.7% (price as of 2026-08-21) |
| March 4, 2025 | BMI | F | 68 | $209.50 | $14,246 | 4,787 Direct | -1.40% | Disposed | -38.6% (price as of 2026-08-21) |
| March 3, 2025 | BMI | F | 48 | $212.13 | $10,182 | 4,855 Direct | -0.98% | Disposed | -39.4% (price as of 2026-08-21) |
| Feb. 13, 2025 | BMI | A | 936 | — | — | 4,903 Direct | +23.59% | Acquired | (price as of 2026-08-21) |
| March 6, 2024 | BMI | F | 384 | $162.92 | $62,561 | 3,967 Direct | -8.83% | Disposed | -21.1% (price as of 2026-08-21) |
| March 1, 2024 | BMI | A | 444 | — | — | 3,533 Direct | +14.37% | Acquired | (price as of 2026-08-21) |
| Feb. 6, 2024 | BMI | A | 818 | — | — | 4,351 Direct | +23.15% | Acquired | (price as of 2026-08-21) |
| March 3, 2023 | BMI | A | 625 | — | — | 3,089 Direct | +25.37% | Acquired | (price as of 2026-08-21) |
| March 4, 2022 | BMI | A | 631 | — | — | 2,464 Direct | +34.42% | Acquired | (price as of 2026-08-21) |
| March 5, 2021 | BMI | A | 525 | — | — | 1,833 Direct | +40.14% | Acquired | (price as of 2026-08-21) |
| Jan. 22, 2021 | BMI | A | 55 | $94.06 | $5,173 | 110 Indirect | +100.00% | Acquired | 36.7% (price as of 2026-08-21) |
| March 6, 2020 | BMI | A | 1,715 | — | — | 1,715 Direct | — | Acquired | (price as of 2026-08-21) |
| March 6, 2020 | BMI | A | 470 | — | — | 1,308 Direct | +56.09% | Acquired | (price as of 2026-08-21) |
| Jan. 23, 2020 | BMI | A | 55 | $64.93 | $3,571 | 55 Indirect | — | Acquired | 98.0% (price as of 2026-08-21) |
| March 1, 2019 | BMI | A | 1,401 | — | — | 1,401 Direct | — | Acquired | (price as of 2026-08-21) |
| March 1, 2019 | BMI | A | 415 | — | — | 838 Direct | +98.11% | Acquired | (price as of 2026-08-21) |
| March 1, 2019 | BMI | A | 423 | — | — | 423 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 6, 2020 | BMI | Stock Options | BMI Common Stock (1,715) | $63.04 | March 6, 2030 | 1,715 | Acquired |
| March 1, 2019 | BMI | Stock Options | BMI Common Stock (1,401) | $59.85 | March 1, 2029 | 1,401 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 3, 2019 | BMI | Common Stock | 0 | Direct |